TIGIT is a Key Inhibitory Checkpoint Receptor in Lymphoma
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2023)
Key words
Programmed Cell Death 1 Receptor,Hematologic Neoplasms,Immune Checkpoint Inhibitors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined